Swiss All Share Index
17.404,67
PKT
-111,16
PKT
-0,63
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.02.25 | UBS Outperform | RBC Capital Markets | |
| 11.02.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 08.02.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 07.02.25 | UBS Halten | DZ BANK | |
| 07.02.25 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 07.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | DocMorris Sell | UBS AG | |
| 06.02.25 | Nestlé Neutral | UBS AG | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 05.02.25 | Nestlé Market-Perform | Bernstein Research | |
| 04.02.25 | Roche Sell | Deutsche Bank AG | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | UBS Hold | Deutsche Bank AG | |
| 04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | Novartis Buy | Deutsche Bank AG | |
| 04.02.25 | UBS Outperform | RBC Capital Markets | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | DocMorris Buy | Jefferies & Company Inc. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.02.25 | Novartis Hold | Deutsche Bank AG | |
| 03.02.25 | Novartis Kaufen | DZ BANK | |
| 03.02.25 | Nestlé Neutral | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. |